KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Change in Cash (2016 - 2025)

Historic Change in Cash for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $113.0 million.

  • Quest Diagnostics' Change in Cash fell 7707.91% to $113.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$332.0 million, marking a year-over-year decrease of 15346.22%. This contributed to the annual value of -$137.0 million for FY2024, which is 13692.72% down from last year.
  • Quest Diagnostics' Change in Cash amounted to $113.0 million in Q3 2025, which was down 7707.91% from $131.0 million recorded in Q2 2025.
  • Quest Diagnostics' 5-year Change in Cash high stood at $543.0 million for Q4 2023, and its period low was -$670.0 million during Q2 2021.
  • For the 5-year period, Quest Diagnostics' Change in Cash averaged around -$38.2 million, with its median value being -$90.0 million (2022).
  • As far as peak fluctuations go, Quest Diagnostics' Change in Cash plummeted by 32222.22% in 2022, and later skyrocketed by 280000.0% in 2024.
  • Quarter analysis of 5 years shows Quest Diagnostics' Change in Cash stood at -$115.0 million in 2021, then crashed by 234.78% to -$385.0 million in 2022, then surged by 241.04% to $543.0 million in 2023, then crashed by 139.59% to -$215.0 million in 2024, then skyrocketed by 152.56% to $113.0 million in 2025.
  • Its Change in Cash was $113.0 million in Q3 2025, compared to $131.0 million in Q2 2025 and -$361.0 million in Q1 2025.